Advanced Development of a Filovirus Vaccine
$611,627N01FY2022AINIH
Janessen Vaccines And Prevention, Bv, Leiden
Investigators
Abstract
This contract supports advanced development of an Filovirus vaccine; support may be provided through early clinical development.
View original record on NIH RePORTER →